Omar Alhalabi

Omar Alhalabi, MD, is an Assistant Professor in the Department of Genitourinary Medical Oncology at The University of Texas MD Anderson Cancer Center, specializing in advanced urothelial carcinoma and genitourinary malignancies. His work bridges clinical practice and translational research.

• Education: Medical Doctor (MD) degree, though specific institution not mentioned in text
• Key Research Areas: Immunotherapy, targeted therapies, genomic biomarkers, and immune-related toxicities in urothelial cancers

Recent publications focus on HER2-targeting strategies, MTAP-deficient cancer therapies, and immune checkpoint inhibitor combinations in genitourinary tumors. He contributes to clinical trials like UNITE and TROPION-PanTumor01, analyzing drug efficacy and safety in variant histologies.